| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 4.8 | 17.9 | 21.6 |
| Other income | 0.0 | 0.1 | 0.1 |
| Total income | 4.8 | 17.9 | 21.6 |
| Profit before exceptional items & tax | -8.0 | 2.7 | 3.2 |
| Profit before tax | -8.0 | 2.7 | 3.2 |
| Net profit | -6.1 | 2.0 | 2.5 |
| Operating margin | -166.7% | 15.1% | 14.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -77.80% |
|---|
NSE results filing, NSE: MEDIORG. Figures extracted from the filing.
Medicamen Organics Ltd: key numbers
- Share price
- ₹24.55
- Market cap
- ₹36.53 Cr
- Revenue (annual)
- ₹22.63 Cr
- Net profit (annual)
- ₹-4.02 Cr
- P/E (TTM)
- -9.1×Sector 47.4×
- Promoter holding
- 54.89%
- FII holding
- 0.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medicamen Organics Ltd
All →Medicamen Organics Annual General Meeting
Medicamen Organics held its 31st AGM on September 25, 2026. Shareholders approved audited financial statements, director reappointment, secretarial auditor appointment, and related party transactions.
Medicamen Organics Other Announcement
Medicamen Organics Limited has re-appointed Ms. Divya Rani as the Secretarial Auditor of the company for a period of 12 months.
Medicamen Organics Other Announcement
Medicamen Organics Limited informed shareholders about the web-link to access the Notice of the 31st AGM and Annual Report for FY 2025-26, as per regulatory compliance.
Medicamen Organics Annual General Meeting
Medicamen Organics Ltd has scheduled its 31st Annual General Meeting for September 25, 2026. The board also approved the re-appointment of its Secretarial Auditors.
Medicamen Organics Management Change
Mr. Brijesh Kumar Chaubey has resigned as Executive Director of Medicamen Organics Limited. The resignation is effective July 20, 2026, due to family medical issues.
Medicamen Organics Fund Raise of ₹12.29 Cr
Medicamen Organics Limited received Rs. 12.29 Crore in consideration for a preferential allotment of equity shares and warrants. The auditor certified compliance with SEBI ICDR Regulations.
- Value
- ₹12.29 Cr